144873-97-2 Usage
General Description
[2-[1-(triphenylmethyl)-1H-tetrazol-5-yl]phenyl]boronic acid is a chemical compound with the molecular formula C27H23BN4O2. It is commonly used in chemical research and pharmaceutical synthesis as a boronic acid derivative. [2-[1-(TRIPHENYLMETHYL)-1H-TETRAZOL-5-YL]PHENYL]BORONIC ACID is a tetrazole-based ligand that contains a boronic acid group, making it useful for its ability to form complexes with other molecules, such as proteins or nucleic acids. It has potential applications in the development of new drugs, particularly as a component in the synthesis of potential pharmaceuticals. Additionally, it has been studied for its potential as a fluorescent probe in bioimaging and as a catalyst in organic synthesis reactions.
Check Digit Verification of cas no
The CAS Registry Mumber 144873-97-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,4,4,8,7 and 3 respectively; the second part has 2 digits, 9 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 144873-97:
(8*1)+(7*4)+(6*4)+(5*8)+(4*7)+(3*3)+(2*9)+(1*7)=162
162 % 10 = 2
So 144873-97-2 is a valid CAS Registry Number.
144873-97-2Relevant articles and documents
The synthesis of radiolabeled Irbesartan using N,N-dimethyl[ 14C]formamide as a source of carbon-14 isotope
Ekhato, I. Victor,Bonacorsi Jr., Samuel
, p. 202 - 205 (2012/05/20)
Irbesartan (Avapro) is in clinical use as an antihypertensive drug. It is a nonpeptide angiotensin II receptor antagonist. A radiolabeled version of this drug, intended for use in environmental fate studies, was prepared from N,N-dimethyl[14C]f
DUAL-ACTING OXAZOLE ANTIHYPERTENSIVE AGENTS
-
Page/Page column 22, (2011/02/18)
In one aspect, the invention relates to compounds having the formula: wherein: Ar, Z, R3, R4 and R5 are as defined in the specification, or a pharmaceutically acceptable salt thereof. These compounds have AT1 re
PROCESSES FOR THE SYNTHESIS OF 5-PHENYL -1 TRITYL-1H-TETRAZOLE
-
Page/Page column 14, (2010/11/30)
Provided are processes for the synthesis of 5 -phenyl- 1-trityl-lH-tetrazole, an intermediate useful in the synthesis of irbesartan.